Infectious Disease CE Activities

RMEI DECISION SUPPORT AIDS

View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
View Details

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.
View Details

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.

LATEST INFECTIOUS DISEASE ARTICLES

RSS Latest Infectious Disease Articles
  • Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge June 7, 2025
    Use of some antifungal pesticides may select for resistant fungi in the environment, which can then endanger human health. Coordinated regulatory processes in this area are important.
    George R. Thompson III, Angel N. Desai
  • A Trial of Trimethoprim–Sulfamethoxazole in Pregnancy to Improve Birth Outcomes June 5, 2025
    In a double-blind, randomized, placebo-controlled trial in Zimbabwe, treatment of mothers with trimethoprim–sulfamethoxazole daily beginning as early as 14 weeks’ gestation did not significantly increase infant birth weight.
    Bernard Chasekwa, Fortunate Munhanzi, Lenin Madhuyu, Gabriel Mbewe, Vincent Mabika, Dzivaidzo Chidhanguro, Tendai Kofi, Jonthan Munengiwa, Hilda Mapfumo, Mercy Musapa, Sipho Shumba, Elizabeth Hungwe, Mary Nhokwara, Nester Bushe, Rudo Kufa, Phatisiwe Mazula, Muchaneta Chikombingo, Alice Tengende, Admire Zanga, Asaph Ziruma, Tsitsi Bere, Success Munyengwa, Charity Mudimbu, Zvikomborero Murwira, Shepherd Mudzingwa, Eddington Mpofu, Batsirai Mutasa, Virginia Sauramba, Elisha Masakadze, Thompson Runodamoto, Courage Chiorera, Alfred Mushininga, Claire D. Bourke, Ruairi C. Robertson, Jeniffer Perussolo, Nikos Donos, Chandiwana Nyachowe, Mary Muchekeza, Jefrey Chikunya, Melanie Smuk, Kuda Mutasa, Naume V. Tavengwa, Lisa L. Langhaug, Robert Ntozini, Stephen P. Munjanja, Andrew J. Prendergast
  • Bedaquiline Activity against Leprosy June 5, 2025
    In this report, 30 patients in Mali with untreated multibacillary leprosy were treated with bedaquiline for 8 weeks, followed by standard multidrug therapy. Cultures were cleared in all the patients with bedaquiline therapy.
    Abdoulaye Fomba, Fadima C. Haidara, Mamoudou Kodio, Catherine Arama, Emmanuelle Cambau, Aurélie Chauffour, Nicolas Veziris, Bettina E. Broeckling, Alaine K. Warren, Bertrand Cauchoix, Alexandre Alcaïs, Laurent Marsollier, Henri Assé, Mary Jackson, Samba Ousmane Sow, Ousmane Faye, Vincent Jarlier, Stewart T. Cole, Charlotte Avanzi, Alexandra Aubry, Roch C. Johnson

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.